Society guideline links: Acute promyelocytic leukemia

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Acute myeloid leukemia" and "Society guideline links: Chronic myeloid leukemia".)

International

●International Society on Thrombosis and Haemostasis (ISTH): Guidance on the management of hemostatic complications in acute leukemia (2020)

Canada

●A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults (2014)

United States

●College of American Pathologists (CAP) and the American Society of Hematology (ASH): Guideline for the initial diagnostic workup of acute leukemia (2017)

●Treatment of patients with acute promyelocytic leukemia – A consensus statement on risk-adapted approaches to therapy (2010)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines for diagnosis, treatment and follow-up on acute myeloid leukaemia in adult patients (2020)

●European LeukemiaNet (ELN): Updated recommendations from an expert panel on the management of acute promyelocytic leukemia (2019)

Japan

●Japanese Society for Hematology (JSH): Guideline for tumors of hematopoietic and lymphoid tissues – Leukemia: 2. Acute promyelocytic leukemia (APL) (2017)